De la mediación editorial a la fragmentación algorítmica
RevCom · 02.10.2026 · (18) · e114
DOI: 10.24215/24517836e114 ↗Kurz gefasst
Fachartikel in der Zeitschrift RevCom, online erschienen am 02.10.2026. Verfasst von Janet Usinger. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The massive emergence of Generative Artificial Intelligence (GenAI) has introduced a structural transformation in the contemporary communication ecosystem. This article proposes analyzing this scenario as the rise of a "synthetic communication ecosystem," in which mediation is no longer limited to the selection or distribution of human content but incorporates the automated generation of plausible discourse. Based on a qualitative and exploratory methodological design, the study examines informational interactions with conversational chatbots (ChatGPT, Gemini, Copilot), utilized as functional substitutes for news media. The results evidence three critical shifts: the dissolution of source traceability, the fragmentation of the public agenda through response personalization, and the construction of informational authority based on rhetorical coherence rather than factual verifiability. It is concluded that, in the face of the commodification of technical writing and discursive inflation, the value of journalistic labor is reconfigured towards ethical, contextual, and public responsibility competencies—non-automatable dimensions that emerge as guarantors of meaning in an environment saturated by algorithmic synthesis.
Zitieren
APA
Usinger, J. (2026). De la mediación editorial a la fragmentación algorítmica. RevCom, e114. https://doi.org/10.24215/24517836e114
Vancouver
Usinger J. De la mediación editorial a la fragmentación algorítmica. RevCom. 2026:e114. doi:10.24215/24517836e114
BibTeX
@article{Usinger2026,
author = {Usinger, Janet},
title = {De la mediación editorial a la fragmentación algorítmica},
journal = {RevCom},
year = {2026},
number = {18},
pages = {e114},
doi = {10.24215/24517836e114}
}
EUVIMED